MEC Plus

New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer
New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer
Alberto Montero, MD, MBA, CPHQ
Endocrine Therapy for Early-Stage Breast Cancer: Who Needs More?
Endocrine Therapy for Early-Stage Breast Cancer: Who Needs More?
Constanza Guaqueta, MD
Early Stage TNBC: Reviewing Different Strategies and Management
Early Stage TNBC: Reviewing Different Strategies and Management
Mark Pegram, MD
ADC in Breast Cancer Management
ADC in Breast Cancer Management
Jane Lowe Meisel, MD
Multiple Myeloma: Triplet? Quadruplet? What is The Best Frontline Therapy and Next Line after First Relapse?
Multiple Myeloma: Triplet? Quadruplet? What is The Best Frontline Therapy and Next Line after First Relapse?
Sagar Lonial, MD, FACP
CAR-T Cell as Strategy for the Management of Hematologic Malignancies
CAR-T Cell as Strategy for the Management of Hematologic Malignancies
Krishna Komanduri, MD
Acute Myeloid Leukemia
Acute Myeloid Leukemia
Martin Tallman, MD
Follicular, Marginal Zone and Mantle Cell NHL: Novel Advances
Follicular, Marginal Zone and Mantle Cell NHL: Novel Advances
Jose Sandoval-Sus, MD, FACP
DLBCL & Hodgkin’s Disease
DLBCL & Hodgkin’s Disease
Eduardo Sotomayor, MD
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
William Wierda, MD, PhD
New Developments in Sarcoma Therapy
New Developments in Sarcoma Therapy
Jonathan C. Trent II, MD, PhD
Ovarian-Uterine & Fallopian Tube Carcinomas
Ovarian-Uterine & Fallopian Tube Carcinomas
Alex Olawaiye, MD, FRCOG, FACOG, FACS
Novel Advances in the Therapy of Kidney and Bladder Carcinomas
Novel Advances in the Therapy of Kidney and Bladder Carcinomas
Pedro M. Barata, MD, MSc